CAS: 2049868-46-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK963 (Racemate) REF: AN-AG01FW4OCAS: 2049868-46-2 | 98+% | A consultar | Mar 14 May 24 |
 | GSK963 REF: TM-T5054CAS: 2049868-46-2 | 98.68% | 35,00 €~543,00 € | Mar 21 May 24 |
 | GSK'963 REF: 3D-ZGD86846CAS: 2049868-46-2 | Min. 95% | A consultar | Mar 25 Jun 24 |
GSK963 (Racemate)
CAS:2049868-46-2
Fórmula:
C14H18N2O
Pureza:
98+%
Forma y color:
Solid
Peso molecular:
230.3055
Ref: AN-AG01FW4O
| 1g | A consultar | |
| 100mg | 564,00 € | |
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
GSK963
CAS:2049868-46-2
GSK963 (Racemate), a structurally distinct, potent and selective inhibitor of RIP1 kinase(IC50=29 nM).
Fórmula:
C14H18N2O
Pureza:
98.68%
Forma y color:
Solid
Peso molecular:
230.31
Ref: TM-T5054
| 1mg | 35,00 € | |
| 2mg | 50,00 € | |
| 5mg | 78,00 € | |
| 10mg | 118,00 € | |
| 25mg | 231,00 € | |
| 50mg | 371,00 € | |
| 100mg | 543,00 € | |
| 1ml*10 (DMSO) | 85,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
GSK'963
CAS:2049868-46-2
GSK'963 is a peptide-based activator of the nicotinic acetylcholine receptor that binds to the α4β2 …
Fórmula:
C14H18N2O
Pureza:
Min. 95%
Peso molecular:
230.31 g/mol
Ref: 3D-ZGD86846
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
